New drug BI 1015550 passes first safety check in small study
NCT ID NCT03542344
First seen Jan 08, 2026 · Last updated May 21, 2026 · Updated 20 times
Summary
This early-stage study tested a new drug called BI 1015550 in 16 healthy Japanese men to see if it is safe and how the body handles it. Participants received a single rising dose of the drug or a placebo. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SOUSEIKAI Sumida Hospital
Tokyo, Sumida-ku, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.